Time from symptom onset to the initiation of treatment of pulmonary tuberculosis in a city with a high incidence of the disease.

Jornal brasileiro de pneumologia : publicaça̋o oficial da Sociedade Brasileira de Pneumologia e Tisilogia
Marina de Loureiro MaiorMarcus Barreto Conde

Abstract

To estimate the time elapsed between the onset of symptoms and the initiation of treatment of pulmonary tuberculosis among treatment-naïve patients with positive results in sputum smear microscopy, and to evaluate the variables associated with delays in diagnosis and in treatment initiation. This was a descriptive exploratory study involving 199 treatment-naïve tuberculosis patients > 12 years of age with AFB-positive sputum smear microscopy results between 2006 and 2008. At their first (treatment initiation) visit to a primary health care clinic in the city of Nova Iguaçu, Brazil, the patients were interviewed and their ancillary test results were reviewed. The medians (and respective interquartile ranges) of the time from symptom onset to the initiation of treatment of pulmonary tuberculosis, from symptom onset to seeking medical attention, from entry into care to diagnosis, and from entry into care to treatment initiation, in weeks, were 11 (6-24), 8 (4-20), 2 (1-8), and 1 (1-1), respectively. The variables gender, age, level of education, previous use of antibiotics, HIV status, site of first medical visit, and radiological extent of tuberculosis showed no associations with the time from entry into care to diagnosis and to ...Continue Reading

References

Apr 16, 1998·Tropical Medicine & International Health : TM & IH·E Jaramillo
Sep 26, 2002·BMC Public Health·Meaza DemissieYemane Berhane
Jun 1, 2004·BMC Public Health·Olumuyiwa O Odusanya, Joseph O Babafemi
Aug 19, 2007·Health Policy and Planning·Fazlul KarimVinod K Diwan
Nov 4, 2008·The European Respiratory Journal·J-P Janssens, H L Rieder
Jun 13, 2009·BMC Infectious Diseases·Chandrashekhar T SreeramareddyJ Van den Ende

❮ Previous
Next ❯

Citations

Jun 8, 2013·Revista da Escola de Enfermagem da U S P·Anneliese Domingues WysockiTereza Cristina Scatena Villa
Oct 2, 2014·Revista brasileira de epidemiologia = Brazilian journal of epidemiology·Regiane de PaulaDaniela Schoeps
Mar 17, 2016·Revista brasileira de epidemiologia = Brazilian journal of epidemiology·Natália Sperli Geraldes Marin dos Santos SasakiFrancisco Chiaravalloti-Neto
Oct 12, 2018·Revista brasileira de enfermagem·Lílian Moura de Lima SpagnoloRoxana Isabel Cardozo Gonzales
Nov 19, 2020·Revista de salud pública·Aguinaldo José de AraújoTânia Maria Ribeiro Monteiro de Figueiredo
Jul 30, 2017·Revista Portuguesa De Pneumologia·S RamosR Duarte

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Jornal brasileiro de pneumologia : publicaça̋o oficial da Sociedade Brasileira de Pneumologia e Tisilogia
Giselle Mota BastosMarcus Barreto Conde
Acta Neurologica Scandinavica
J GroseljTOP-INT-51 Investigators' Group
Jornal brasileiro de pneumologia : publicaça̋o oficial da Sociedade Brasileira de Pneumologia e Tisilogia
Simone Teresinha Aloise CampaniCarlos Nunes Tietbohel
© 2021 Meta ULC. All rights reserved